• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

PC3 是一种具有前列腺小细胞癌特征的细胞系。

PC3 is a cell line characteristic of prostatic small cell carcinoma.

机构信息

Department of Pathology, Jonsson Comprehensive Cancer Center and Broad Center for Regenerative Medicine and Stem Cell Biology, David Geffen School of Medicine at UCLA, Los Angeles, California 90095-1732, USA.

出版信息

Prostate. 2011 Nov;71(15):1668-79. doi: 10.1002/pros.21383. Epub 2011 Mar 22.

DOI:10.1002/pros.21383
PMID:21432867
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3426349/
Abstract

BACKGROUND

The majority of the prostatic cancers are adenocarcinomas characterized by glandular formation and the expression of luminal differentiation markers androgen receptor (AR) and prostate-specific antigen (PSA). Most adenocarcinomas are indolent and androgen-dependent. Hormonal therapy that inhibits AR signaling produces symptomatic relief in patients with advanced and metastatic adenocarcinomas. Prostatic small cell neuroendocrine carcinoma (SCNC) is a variant form of prostate cancer (PC). In contrast to adenocarcinoma, the tumor cells of SCNC do not form glands and are negative for AR and PSA. SCNC is extremely aggressive and does not respond to hormonal therapy. The purpose of this study was to compare the important and relevant features of two most commonly used PC cell lines, LNCaP and PC3, with prostatic adenocarcinoma and SCNC.

METHODS

Xenograft tumors of LNCaP and PC3 were prepared and compared with human prostatic adenocarcinoma and SCNC for the expression of key signaling molecules by immunohistochemistry and Western blot analysis.

RESULTS

LNCaP cells express AR and PSA and their growth is inhibited by androgen withdrawal, similar to human prostatic adenocarcinoma. PC3 cells do not express AR and PSA and their proliferation is independent of androgen, similar to SCNC. Adenocarcinoma cells and LNCaP cells are negative for neuroendocrine markers and stem cell-associated marker CD44 while SCNC and PC3 cells are positive. LNCaP cells have identical cytokeratin profiles to adenocarcinoma while PC3 cells have cytokeratin profiles similar to SCNC.

CONCLUSION

LNCaP cells share common features with adenocarcinoma while PC3 cells are characteristic of SCNC.

摘要

背景

大多数前列腺癌是腺癌,其特征是腺体形成和管腔分化标志物雄激素受体 (AR) 和前列腺特异性抗原 (PSA) 的表达。大多数腺癌是惰性的和雄激素依赖性的。抑制 AR 信号的激素治疗可缓解晚期和转移性腺癌患者的症状。前列腺小细胞神经内分泌癌 (SCNC) 是前列腺癌 (PC) 的一种变体。与腺癌不同,SCNC 的肿瘤细胞不形成腺体,并且 AR 和 PSA 均为阴性。SCNC 具有极强的侵袭性,且对激素治疗无反应。本研究的目的是比较两种最常用的 PC 细胞系 LNCaP 和 PC3 与前列腺腺癌和 SCNC 的重要和相关特征。

方法

制备 LNCaP 和 PC3 的异种移植肿瘤,并通过免疫组织化学和 Western blot 分析与人类前列腺腺癌和 SCNC 进行比较,以检测关键信号分子的表达。

结果

LNCaP 细胞表达 AR 和 PSA,其生长受雄激素剥夺抑制,类似于人类前列腺腺癌。PC3 细胞不表达 AR 和 PSA,其增殖不受雄激素影响,类似于 SCNC。腺癌细胞和 LNCaP 细胞均为神经内分泌标志物和干细胞相关标志物 CD44 阴性,而 SCNC 和 PC3 细胞均为阳性。LNCaP 细胞的细胞角蛋白谱与腺癌相同,而 PC3 细胞的细胞角蛋白谱与 SCNC 相似。

结论

LNCaP 细胞与腺癌具有共同特征,而 PC3 细胞是 SCNC 的特征。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c595/3426349/a8a38e894847/nihms397040f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c595/3426349/d5d545328287/nihms397040f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c595/3426349/3c933fd3deaa/nihms397040f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c595/3426349/f56e97086780/nihms397040f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c595/3426349/75036bf10199/nihms397040f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c595/3426349/8cf8edb54d7b/nihms397040f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c595/3426349/6e8cf977a0b5/nihms397040f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c595/3426349/a8a38e894847/nihms397040f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c595/3426349/d5d545328287/nihms397040f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c595/3426349/3c933fd3deaa/nihms397040f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c595/3426349/f56e97086780/nihms397040f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c595/3426349/75036bf10199/nihms397040f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c595/3426349/8cf8edb54d7b/nihms397040f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c595/3426349/6e8cf977a0b5/nihms397040f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c595/3426349/a8a38e894847/nihms397040f7.jpg

相似文献

1
PC3 is a cell line characteristic of prostatic small cell carcinoma.PC3 是一种具有前列腺小细胞癌特征的细胞系。
Prostate. 2011 Nov;71(15):1668-79. doi: 10.1002/pros.21383. Epub 2011 Mar 22.
2
Smoothened loss is a characteristic of neuroendocrine prostate cancer. smoothened 失活是神经内分泌前列腺癌的一个特征。
Prostate. 2021 Jun;81(9):508-520. doi: 10.1002/pros.24122. Epub 2021 May 6.
3
Pathogenesis of prostatic small cell carcinoma involves the inactivation of the P53 pathway.前列腺小细胞癌的发病机制涉及 P53 通路的失活。
Endocr Relat Cancer. 2012 May 24;19(3):321-31. doi: 10.1530/ERC-11-0368. Print 2012 Jun.
4
NE-10 neuroendocrine cancer promotes the LNCaP xenograft growth in castrated mice.NE-10神经内分泌癌促进去势小鼠体内LNCaP异种移植瘤的生长。
Cancer Res. 2004 Aug 1;64(15):5489-95. doi: 10.1158/0008-5472.CAN-03-3117.
5
Antiandrogenic effects of novel androgen synthesis inhibitors on hormone-dependent prostate cancer.新型雄激素合成抑制剂对激素依赖性前列腺癌的抗雄激素作用
Cancer Res. 2000 Dec 1;60(23):6630-40.
6
Neuroendocrine differentiation in usual-type prostatic adenocarcinoma: Molecular characterization and clinical significance.神经内分泌分化在普通型前列腺腺癌中的表现:分子特征及临床意义。
Prostate. 2020 Sep;80(12):1012-1023. doi: 10.1002/pros.24035. Epub 2020 Jul 10.
7
Telomere lengths differ significantly between small-cell neuroendocrine prostate carcinoma and adenocarcinoma of the prostate.端粒长度在小细胞神经内分泌前列腺癌和前列腺腺癌之间有显著差异。
Hum Pathol. 2020 Jul;101:70-79. doi: 10.1016/j.humpath.2020.04.014. Epub 2020 May 7.
8
CD44 expression is a feature of prostatic small cell carcinoma and distinguishes it from its mimickers.CD44表达是前列腺小细胞癌的一个特征,可将其与其模仿者区分开来。
Hum Pathol. 2009 Feb;40(2):252-8. doi: 10.1016/j.humpath.2008.07.014. Epub 2008 Oct 5.
9
Androgen receptor as a regulator of ZEB2 expression and its implications in epithelial-to-mesenchymal transition in prostate cancer.雄激素受体作为 ZEB2 表达的调节剂及其在前列腺癌上皮间质转化中的意义。
Endocr Relat Cancer. 2014 May 8;21(3):473-86. doi: 10.1530/ERC-13-0514. Print 2014 Jun.
10
Prostate-specific antigen (PSA) promoter-driven androgen-inducible expression of sodium iodide symporter in prostate cancer cell lines.前列腺特异性抗原(PSA)启动子驱动的碘化钠同向转运体在前列腺癌细胞系中的雄激素诱导表达。
Cancer Res. 1999 May 1;59(9):2136-41.

引用本文的文献

1
Engineering of Humanized PSMA-Directed CAR T Cells for Potent and Specific Elimination of Prostate Cancer Cells.用于有效且特异性消除前列腺癌细胞的人源化PSMA导向嵌合抗原受体T细胞的工程设计
Cells. 2025 Aug 28;14(17):1333. doi: 10.3390/cells14171333.
2
Fumiquinazolines F and G from the Fungus Demonstrates Anticancer Efficacy Against Triple-Negative Breast Cancer MDA-MB-231 Cells by Inhibiting Epithelial-Mesenchymal Transition.来自真菌的烟曲喹唑啉F和G通过抑制上皮-间质转化对三阴性乳腺癌MDA-MB-231细胞显示出抗癌功效。
Int J Mol Sci. 2025 Aug 5;26(15):7582. doi: 10.3390/ijms26157582.
3
Elevated NPM1 and FBL expression correlates with prostate cancer aggressiveness and progression.

本文引用的文献

1
Monoclonal antibody targeting of N-cadherin inhibits prostate cancer growth, metastasis and castration resistance.靶向 N-钙黏蛋白的单克隆抗体抑制前列腺癌生长、转移和去势抵抗。
Nat Med. 2010 Dec;16(12):1414-20. doi: 10.1038/nm.2236. Epub 2010 Nov 7.
2
Identification of a cell of origin for human prostate cancer.鉴定人类前列腺癌的起源细胞。
Science. 2010 Jul 30;329(5991):568-71. doi: 10.1126/science.1189992.
3
Paracrine factors produced by bone marrow stromal cells induce apoptosis and neuroendocrine differentiation in prostate cancer cells.
NPM1和FBL表达升高与前列腺癌的侵袭性和进展相关。
J Pathol. 2025 Sep;267(1):56-68. doi: 10.1002/path.6447. Epub 2025 Jul 24.
4
The human RNASET2 alarmin-like molecule differentially affects prostate cancer cells behavior in both cell autonomous and non-cell autonomous manners.人类RNASET2警报素样分子以细胞自主和非细胞自主方式差异性地影响前列腺癌细胞的行为。
J Transl Med. 2025 May 19;23(1):560. doi: 10.1186/s12967-025-06540-0.
5
7,7-Bis(3-Indolyl)--Cresol, a Metabolite from Marine-Derived Bacterium spp. DJA11, Suppresses the Proliferation and Motility of Prostate Cancer Cells.7,7-双(3-吲哚基)-对甲酚,一种源自海洋细菌spp. DJA11的代谢产物,可抑制前列腺癌细胞的增殖和运动能力。
J Microbiol Biotechnol. 2025 May 15;35:e2502035. doi: 10.4014/jmb.2502.02035.
6
Inhibition of Mitochondrial-Associated Protein MAGMAS Resensitizes Chemoresistant Prostate Cancer Cells to Docetaxel.抑制线粒体相关蛋白MAGMAS可使耐多西他赛的前列腺癌细胞重新对多西他赛敏感。
Cancers (Basel). 2025 Apr 30;17(9):1535. doi: 10.3390/cancers17091535.
7
Solvent-Free Process for Preparing Metal-Organic Framework Composites Based on Carbon-Based Quantum Dots and Their Derivatives as Drug Delivery Systems for Andrographolide.基于碳基量子点及其衍生物制备金属有机骨架复合材料作为穿心莲内酯药物递送系统的无溶剂工艺
Chemistry. 2025 Jun 17;31(34):e202500655. doi: 10.1002/chem.202500655. Epub 2025 May 12.
8
Proteomic profiling of exosomes leads to the identification of a candidate biomarker for prostate cancer progression.外泌体的蛋白质组分析有助于鉴定前列腺癌进展的候选生物标志物。
Genes Dis. 2024 Nov 12;12(4):101463. doi: 10.1016/j.gendis.2024.101463. eCollection 2025 Jul.
9
Preclinical Development of a Genetically Engineered Albumin-Binding Nanoparticle of Paclitaxel.紫杉醇基因工程白蛋白结合纳米粒的临床前开发
Small Sci. 2024 Sep 25;4(11):2400153. doi: 10.1002/smsc.202400153. eCollection 2024 Nov.
10
Terbinafine for prostate cancer: development of coated zein nanospheres for ameliorated pro-apoptosis in PC3 cells.用于前列腺癌的特比萘芬:制备用于改善PC3细胞促凋亡作用的玉米醇溶蛋白包衣纳米球
Nanomedicine (Lond). 2025 Apr;20(8):817-833. doi: 10.1080/17435889.2025.2481823. Epub 2025 Apr 2.
骨髓基质细胞产生的旁分泌因子诱导前列腺癌细胞凋亡和神经内分泌分化。
Prostate. 2011 Feb 1;71(2):157-67. doi: 10.1002/pros.21231.
4
New agents and strategies for the hormonal treatment of castration-resistant prostate cancer.用于去势抵抗性前列腺癌的激素治疗的新药物和新策略。
Expert Opin Investig Drugs. 2010 Jul;19(7):837-46. doi: 10.1517/13543784.2010.494178.
5
Wnt-11 promotes neuroendocrine-like differentiation, survival and migration of prostate cancer cells.Wnt-11 促进前列腺癌细胞的神经内分泌样分化、存活和迁移。
Mol Cancer. 2010 Mar 10;9:55. doi: 10.1186/1476-4598-9-55.
6
Basal epithelial stem cells are efficient targets for prostate cancer initiation.基底上皮干细胞是前列腺癌起始的有效靶点。
Proc Natl Acad Sci U S A. 2010 Feb 9;107(6):2610-5. doi: 10.1073/pnas.0913873107. Epub 2010 Jan 25.
7
Androgen-responsive and -unresponsive prostate cancer cell lines respond differently to stimuli inducing neuroendocrine differentiation.雄激素反应性和非反应性前列腺癌细胞系对诱导神经内分泌分化的刺激有不同反应。
Int J Androl. 2010 Dec;33(6):784-93. doi: 10.1111/j.1365-2605.2009.01030.x.
8
Neuroendocrine differentiation in prostate cancer.前列腺癌中的神经内分泌分化
Am J Transl Res. 2009 Feb 5;1(2):148-62.
9
Lin-Sca-1+CD49fhigh stem/progenitors are tumor-initiating cells in the Pten-null prostate cancer model.在Pten基因缺失的前列腺癌模型中,Lin-Sca-1+CD49f高表达的干/祖细胞是肿瘤起始细胞。
Cancer Res. 2009 Nov 15;69(22):8555-62. doi: 10.1158/0008-5472.CAN-08-4673. Epub 2009 Nov 3.
10
A luminal epithelial stem cell that is a cell of origin for prostate cancer.一种作为前列腺癌起源细胞的管腔上皮干细胞。
Nature. 2009 Sep 24;461(7263):495-500. doi: 10.1038/nature08361. Epub 2009 Sep 9.